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ABSTRACT The genome of human immunodeficiency vi-
rus type 1 (HIV-1) encodes at least six proteins involved in
regulation as well as the structural proteins Gag, Pol, and Env.
The interplay of the various regulators generates early and late
transcriptional phases in the HIV-1 life cycle; the earliest RNA
is enriched in subgenomic species, and the genomic transcript
appears at the later stage of infection. We investigated the
nature of the mRNAs expressed in the early stages of infection
when the 2 kilobase subgenomic species predominate. RNA was
analyzed in the earl phase of a one-step growth cycle ofHIV-1
infection in T-lymphoid and monocytic cell lines by using PCR
amplification of in vitro-synthesized viral cDNAs. In both cell
lines, expression of Tat-, Rev-, and Nef-specific messages
appeared simultaneously and could be detected within 8-12 hr
of infection but in different amounts with a predominance of
Nef-specific message. The Env-specific message could be de-
tected as early as the Rev-specific message, indicating that
expression of at least small amounts of the singly spliced
message could occur before the accumulation of Rev.
The human immunodeficiency type 1 (HIV-1) genome con-
tains at least six genes that may be involved in regulation in
addition to the structural genes common to all retroviruses,
env, pol, and gag. There is an emerging picture of a complex
pattern of regulation of the virus mediated by at least two of
the transregulatory proteins, Tat and Rev. While Tat in-
creases expression from the HIV-1 long terminal repeat,
resulting in enhanced expression of all viral genes (1), Rev
differentially enhances the expression of the unspliced or
singly spliced messages coding primarily for structural genes
and genomic RNA (2-6). It has been shown that there is a
controlled temporal pattern ofexpression ofHIV RNAs upon
acute infection; the earliest RNA is enriched in subgenomic
species, and the genomic transcripts appear at the later stage
of infection (7). This same pattern has been noted when
chronically infected low-expression cell lines are stimulated
with agents that activate the HIV-1 long terminal repeat (8).
It is not yet known which specific genes are being expressed
at the early stages of HIV-1 infection and activation. Such a
pattern of transcriptional phases has been well described in
other viruses, such as simian virus 40, polyoma virus, and
herpesviruses, where early and late phases of transcription
can be differentiated (9). In these instances the genes are
regulated by unique promoters, whereas in HIV-1 a single
promoter regulates expression of all genes.
The mRNAs of all HIV-1 proteins are processed from the
same precursor RNA with alternative splicing allowing for
protein diversity. The mRNAs coding for the regulatory
proteins Tat, Rev, and Nef are doubly spliced with identical
5' and 3' exons, differing in the splice acceptor of the second
exon. The determination of splice-site use provides an im-
portant additional means of posttranscriptional regulation
(10), particularly in light of the different regulatory functions
associated with the proteins encoded by these transcripts. To
better understand the control of early events that occur upon
acute infection we examined the kinetics of splicing involved
in the expression of viral genes, particularly the regulatory
genes. We studied the early events during a one-step growth
cycle in the T-lymphoid and monocytic cell lines. PCR
amplification of in vitro-synthesized cDNAs with subsequent
oligonucleotide hybridization was used for the specific and
sensitive detection of the spliced HIV messages. Unlike
conventional RNA (Northern) blot analysis, this method
allowed us to distinguish the specific splicing events involved
in the expression of Tat, Rev, and Nef mRNA as well as of
Vif and Env. Increased synthesis of specific mRNAs for
regulatory proteins could be detected 8-12 hr after infection
in both lymphocyte and monocyte cell lines. The patterns of
splicing and relative abundance of the regulatory gene mes-
sages were identical in both of these cell lines. Although the
regulatory mRNAs appeared simultaneously, the doubly
spliced NefmRNA was always more abundant relative to the
doubly spliced mRNA coding for Rev and Tat. The singly
spliced RNA capable of coding for Env could be detected as
early as the regulatory messages by using this sensitive
means of detection.
MATERIALS AND METHODS
Virus and Infection. Host cells for HIV-1 infection were H9
and U937, T-lymphoid and monocytic cell lines, respectively.
The virus strain used was HIV-1WI3, which grows preferen-
tially in T cells. A high-titer viral stock was made by the
shaking method (7). The same number of H9 and U937 cells
was infected with equal amounts of virus as described (7). At
appropriate time points, samples were taken for RNA isola-
tion. RNA from uninfected H9 cells as well as from H9 cells
chronically infected with HIV-1II1B was analyzed.
RNA Preparation. Preparation of the total cellular RNA
was as described by Kim et al. (7).
cDNA Synthesis and PCR Amplification. Synthetic oligo-
nucleotide primers and probes were used for cDNA synthe-
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sis, PCR amplification, and hybridization detection of spe-
cific HIV cDNAs. The cDNAs were synthesized in a stan-
dard reverse transcriptase reaction. The reaction buffer
containing 50 mM Tris HCl (pH 8.0), 3.0 mM MgCl2, and 75
mM KCI mixed with 200 ng of primer and 2 ,g of total cellular
RNA was heated to 65TC and slowly cooled to 24TC to allow
primer annealing. Sixty units of avian myeloblastosis virus
reverse transcriptase (Super Reverse Transcriptase; Molec-
ular Genetics Resources, Tampa, FL) was added along with
a mixture ofdNTPs and dithiothreitol to a final concentration
of 1 mM and 8 mM, respectively. The reaction was done at
40TC for 1 hr. Five microliters of the cDNA reaction was used
directly in the amplification reaction.
Each antisense primer was paired with the same-sense
primer, designated US, which is located upstream from the
first major splice donor at the 5' end of the genome, for
amplification of specific cDNAs. The PCR included the sense
and antisense primers at a final concentration of 0.5 tkM,
reaction buffer of 10 mM Tris HCI (pH 8.3), 50 mM KCI, 1.5
mM MgCl2, and 0.01% gelatin, 200 ,tM of each dNTP, 2.5
units of Taq polymerase (Perkin-Elmer/Cetus), and 5 ,u1 from
the reverse transcriptase reaction as the cDNA template. The
samples were amplified through 30 cycles that included the
following parameters: denaturation at 92°C for 1 min, primer
annealing at 55°C for 2 min, and primer extension at 72°C for
2 min. The final cycle included a 7-min extension at 720C.
Oligonucleotide Primers and Probes. Oligonucleotide prim-
ers and probes were made on an Applied Biosystems syn-
thesizer. The location of the primers and probes used for
cDNA synthesis and detection, as well as their sequences, is
indicated in Figs. 1 and 2A, respectively. The primer desig-
nated ART7 is derived from the third exon of the regulatory
genes tat, rev, and nef, the primer ART5 is downstream from
the splice acceptor for vif, and the primer ART2 is down-
stream from the initiation codon of env. In each case, the
primer pairs used for amplification spanned known splice
junctions for the regulatory and env genes illustrated below
the primers in Fig. 1 and were anticipated to yield specific
products, as predicted by the known HIV-1 splice sites (Fig.
2B). The combination of primers ART7/US was used to
amplify the doubly spliced mRNAs for the regulatory pro-
teins Tat, Rev, and Nef; the primer pair ART5/US used to
amplify the first splice junction of VifmRNA and ART2/US
was used to amplify spliced Env mRNA. The viral probe
designated S1 was used to detect tat-specific cDNA and is
located in the second exon upstream from the rev and nef
splice acceptors. The probe S2 was used to detect both tat-
and rev-specific cDNAs and is located in the second exon of
rev upstream from the nef splice acceptor. The probe S3
located at the 3' end of the second exon common to Tat, Rev,
and Nef messages was used to detect these cDNAs as well as
env cDNA. A specific probe (S4) spanning 14 batses on either
side of the first splice junction of vif was used to detect this
message. Additional oligonucleotide probes derived from the
two small exons upstream from tat (12), ART9 and ART8,
and from the third exon of the mRNAs coding for the
regulatory proteins, S5, were used to identify additional
amplified cDNAs.
Gel Electrophoresis and Hybridization. The PCR products
(25 ,ul of the reaction) were resolved on 5% nondenaturing
polyacrylamide gels, denatured with 0.5 M NaOH/1.5 M
NaCI, neutralized in 0.5 M Tris HCI (pH 8.0)/1.5 M NaCl,
and transferred electrophoretically onto Nytran membranes
(Schleicher & Schuell) using 20 V over 18 hr in 1x TBE buffer
(0.89 M Tris/0.89 M boric acid/0.02 M EDTA, pH 8.3). The
nucleic acid was bound to the membrane by UV irradiation
using the UV Stratalinker 1800 (Stratagene). The membranes
were prehybridized in 6x NET (20x NET is 3 M NaCI/20
mM EDTA/0.3 M Tris-HCl, pH 8.0)/0.1% SDS/5x Den-
hardt's solution/tRNA at 150 ,ug/ml. Oligonucleotide probe
end-labeled with [32P]ATP by standard methods using T4
polynucleotide kinase was added to the prehybridization
solution at 1 x 106 cpm/ml of solution. After overnight
hybridization, the membrane was washed in 6x NET/0.1%
SDS at room temperature twice for 15 min and in the same
solution at 55°C. After autoradiography, each probe was
stripped from the filter by treatment with 0.5 M NaOH/1.5 M
NaCl before hybridization with another probe.
RESULTS
To investigate the structure of the RNA species expressed
during chronic infection, cDNAs were synthesized and am-
plified from RNA prepared from chronically infected H9
cells. When the PCR products generated with primer pair
ART7/US were hybridized with the S1 probe, there was a
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FIG. 1. Structures of unspliced and spliced mRNAs coding for HIV-1 proteins. Primers used for cDNA synthesis and PCR amplification
are indicated by arrows. Direction of arrow indicates primer orientation. Those primers designated ART are antisense primers, and those
designated US are sense primers. Location of oligonucleotides used as probes is indicated above the appropriate exon. The thin line represents
genomic DNA with the flanking long terminal repeat, and thick lines represent exons. Closed arrowheads at the bottom indicate splice donors;
open arrowheads indicate splice acceptors. Nucleotide numbering is according to Ratner et al. (11).
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FIG. 2. (A) Nucleotide sequences of primers and probes. Several
primers have the restriction sites, as indicated by the box, with
additional 5' sequence to allow for cloning of PCR products. The first
5' nucleotide ofthe specific HIV-1 sequence is indicated. (B) Specific
primer pairs and probes used to detect the indicated PCR products.
predominant band of 402 bases representing the doubly
spliced message capable of coding for Tat (Fig. 3A, lane 14).
The probe S2 detected two prominent bands of 402 and
219/225 representing tat and rev cDNAs, respectively (Fig.
3B, lane 14). Cloning and sequencing ofrev-specific amplified
cDNAs revealed a mixture of two previously reported splice
acceptors for Rev-specific message (13-16). When probe S3
was used on the same gel, an additional prominent band was
detected below the 219/225-base-pair (bp) band, and this was
as predicted, 203 bp representing the spliced cDNA capable
of coding for Nef (Fig. 3C, lane 14). Several of the less
prominent bands in lanes 14 in Fig. 3 also hybridized to probe
ART8 or ART9 and, therefore, represent Tat-, Rev-, and
Nef-specific messages with additional upstream exons.
In lymphocytes, the specific Tat message could be detected
as early as 4 hr after infection with significant increases seen
between 12 and 16 hr in both cell lines (Fig. 3A). The
Rev-specific 219/225-bp message could also be faintly de-
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FIG. 3. Temporal expression of specific mRNAs for regulatory
proteins from HIV-1-infected U937 and H9 cell lines. cDNA was
synthesized by using the antisense primer ART7 and amplified with
the primer pair ART7/US. Each autoradiogram is a 24-hr exposure.
The numbers above each lane indicate time of RNA extraction after
viral infection. H9/HIVIIIB represents amplified cDNA synthesized
from chronically infected H9 cells, whereas time 0 and H9 represent
amplified cDNA synthesized from uninfected cells. (A) Temporal
expression of tat-specific mRNA detected with probe S1. (B) Tem-
poral expression ofTat- and Rev-specific mRNA detected with probe
S2. (C) Temporal expression of Tat-, Rev-, and Nef-specific mRNA
detected with probe S3.
tected at 4 hr in the lymphocytes but did not increase
significantly until 12-16 hr in both cell lines (Fig. 3B). The
203-bp band seen with probe S3 in Fig. 3C representing a
nef-coding cDNA was detected as early as the other regula-
tory messages in the lymphocyte cell line and significantly
increased by 12 hr postinfection. (It is possible that the faint
signals seen at 4 hr in the RNA extracted from lymphocytes
could represent spliced mRNA in the viral preparation used
to inoculate the cells; however, it was not seen in the 4-hr
monocyte preparation.) Because the same primer pair and
PCR reaction were used to identify all three regulatory
messages, the messages could be quantitatively compared
when probe S3 was used to detect all three cDNAs. In both
cell lines, the nef-specific cDNA was more abundant at all
time points than the doubly spliced messages coding for Rev
and Tat. In H9 and U937 cell lines, the pattern of expression
and relative abundance of the cDNAs coding for the regula-
tory proteins were identical, although detectable expression
of the regulatory messages appeared to be delayed by 4 hr in
the monocytes.
Expression of message using the splice site for VifmRNA
was not readily detected before 16 hr after infection in both
cell lines (Fig. 4); however, because a different primer pair
and probe were used for amplification and detection, a
quantitative comparison relative to the other regulatory
mRNAs could not be made. This splice site is used for the
expression of both singly and doubly spliced mRNA coding
for Vif as well as by a small noncoding exon that has been
found in multiply spliced variants of Tat-, Rev-, and Nef-
specific mRNA (Fig. 1) (15).
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FIG. 4. Temporal expression of specific mRNAs using the splice
acceptor for Vif protein from HIV-infected U937 and H9 cell lines.
cDNA was synthesized using the antisense primer ART5 and am-
plified with the primer pair ART5/US. The product was identified
with probe S4. Lanes are as indicated in Fig. 3.
The primer pair ART2/US, as predicted, amplified a
predominant product of 466 bases and a less prominent larger
band that was 665 bases (Fig. 5). These are the predicted
singly spliced messages capable of coding for Env using the
splice acceptors for Nef and Tat, respectively (12, 13) (Fig.
1). In both cell lines, env cDNA could readily be detected
before 12 hr after infection on a 24-hr exposure of the
autoradiogram (Fig. 5); however fainter bands could be
detected as early as regulatory cDNAs in both cell lines with
longer exposure of the autoradiogram
DISCUSSION
The method of cDNA synthesis and PCR amplification was
highly sensitive and specific for the detection of the doubly
spliced messages capable of coding for Tat, Rev, and Nef
proteins. This method allowed for the distinction between
these messages that are very similar in size and have exten-
sive overlap of their reading frames and that cannot be
distinguished by standard methods. This method should
allow for the study of expression of these messages in vivo,
where the relative abundance of the messages does not
generally allow detection or distinction by other methods.
It has been demonstrated (7, 8) that a temporal pattern of
RNA accumulation exists in early in vitro HIV-1 infection as
well as in early reactivation of virus from chronically infected
lines. We further investigated and identified the specific
subgenomic messages expressed during the early phase of the
productive infection when the 2-kilobase (kb) subgenomic
mRNA species predominates. Our results indicate that the
2-kb spliced messages capable of coding for the specific
regulatory proteins Tat, Rev, and Nef can be detected early
after infection in both lymphocytes and monocytes and are
expressed simultaneously rather than sequentially, although
in different amounts relative to each other. The overall
pattern ofexpression ofthe doubly spliced Tat, Rev, Nef, and
U 937 H9
0 4 8 12 16 21 0 4 8 12 16 21 H9/HIVIII B
lane 1 2 3 4 5 6 7 8 9 10 11 12 13
FIG. 5. Temporal expression of specific mRNAs for Env protein
from HIV-infected U937 and H9 cell lines. cDNA was synthesized
using the antisense primer ART2 and amplified with the primer pair
ART2/US. The product was identified using probe S3. Lanes are as
indicated in Fig. 3.
spliced Vifmessages as well as their relative abundance were
similar in both cell lines.
The simultaneous expression of doubly spliced regulatory
messages is consistent with the presence ofa single promoter;
however, there are potentially important differences in the
quantity of the specific messages. The Nef-specific mRNA
was overproduced relative to Tat (and to a lesser extent Rev)
at all time points examined in the acute infection as well as
in the chronically infected cell line. The relative abundance
of Nef mRNA agrees with recent work by others (14, 15).
Robert-Guroff et al. (14), using similar methods, demon-
strated a predominance of Nef-specific small mRNAs in H9
cells chronically infected with HIV-1IIIB as well as in periph-
eral blood monocyte/macrophages acutely infected with the
HIV-1Ba-L strain. However, they observed a predominance
of a two-exon message for Nef in the peripheral blood
monocyte/macrophages, which we did not observe in the
acutely infected monocyte line U937 (data not shown). Gua-
telli et al. (16) also demonstrated the predominant use of the
second-exon splice acceptor for the Nef-coding mRNA;
however, because of the location of the primers used, they
could not distinguish singly from doubly spliced messages
because both Env-specific and Nef-specific messages use this
acceptor (16).
Singly spliced Env-specific message could be detected by
PCR in both cell lines simultaneously with Rev, consistent
with our previous Northern hybridization analysis (7, 17).
These results suggest that at least small quantities of singly
spliced messages do not require prior accumulation of the
Rev protein. This is not surprising in light of the extreme
sensitivity of this detection method. Further quantitative
comparisons cannot be made because these messages were
detected with different primer pairs that can vary signifi-
cantly in efficiency of amplification. The accumulation of
Tat- and Rev-specific mRNA may be required before the
appearance of unspliced genomic RNA, but it is difficult to
distinguish amplified proviral DNA from genomic RNA by
this method.
The differential expression of the doubly spliced messages
represents another important posttranscriptional means of
regulation of virus replication. It is known that the viral
protein Rev acts posttranscriptionally in trans to enhance the
expression of the singly spliced and unspliced structural
mRNAs and genomic RNA (2-6). The mechanism(s) of
control resulting in the balanced expression of the individual
multiply spliced mRNAs coding for the regulatory genes is
unknown. Our similar results in two different cell lines using
the same virus do not exclude the possibility that cell factors
acting in trans might influence this relative expression. Work
done with other retroviruses supports the importance of the
relative efficiencies of splice acceptors in the controlled
expression of viral genes. The inefficient splice acceptor of
the Env mRNA of avian sarcoma virus results in a balanced
expression of spliced and unspliced mRNA. This ineffi-
ciency, at least in part, is mediated through the specific
cis-acting sequences recognized by the cellular splicing ma-
chinery (18). The contribution of cis-acting sequences and
trans-acting cellular factors to our observed differences in the
efficiency ofsplice-acceptor use and mRNA expression is not
known. The significance of the relative and persistent abun-
dance of the Nef message remains unclear due to the uncer-
tain role its gene product plays in the virus life cycle (19-25).
In light of the unique activities of the proteins coded for by
these multiply spliced mRNAs, understanding the control
mechanism of such differential RNA expression will be vital
to unraveling the pathogenetic mechanism of HIV-1.
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